This menu provides the list of EV proteins identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
UniProt accession
UniProt name
Protein name
Gene symbol
Species
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Breast cancer cell (BT549)
Breast cancer cell (MCF7)
Breast cancer cell (MDA-MB-231)
Breast cancer cell (MDA-MB-468)
Breast cancer cell (T-47D)
Central nervous system cancer cell (SF268)
Central nervous system cancer cell (SF295)
Central nervous system cancer cell (SF539)
Central nervous system cancer cell (SNB-19)
Central nervous system cancer cell (SNB-75)
Central nervous system cancer cell (U251)
Cerebral microvascular endothelial cell (hCMEC/D3)
Cervical cancer (HeLa)
Chronic lymphoid leukemia cell (JVM-3)
Chronic lymphoid leukemia cell (MEC-1)
Colon cancer cell (Colo205)
Colon cancer cell (DKO-1)
Colon cancer cell (DKs-8)
Colon cancer cell (DLD-1)
Colon cancer cell (HCC 2998)
Colon cancer cell (HCT-116)
Colon cancer cell (HCT-15)
Colon cancer cell (HT29)
Colon cancer cell (KM12)
Colon cancer cell (SW620)
Colorectal cancer cell (HT29)
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Colorectal cancer cells (HCT116, DLD1, SW480, SW620)
Embryonic kidney cell (293T)
Embryonic kidney cell (HEK293)
Endothelial cell (HMEC-1)
Endothelial cell (HUVEC)
Epithelial ovarian carcinoma cell (OVCAR3, OVCAR433, OVCAR5 , SKOV3)
Glioblastoma cell (U87)
Hepatocellular carcinoma cell (97H)
Hepatocellular carcinoma cell (Hep3B)
Hepatocellular carcinoma cell (Huh7)
Hepatocellular carcinoma cell (LM3)
Immortalized prostate epithelial cell line (RWPE-1)
Kidney cancer cell (A498)
Kidney cancer cell (ACHN)
Kidney cancer cell (RXF 393)
Kidney cancer cell (TK-10)
Leukemia cell (CCRF-CEM)
Leukemia cell (HL-60)
Leukemia cell (K562)
Leukemia cell (MOLT-4)
Leukemia cell (RPMI-8226)
Leukemia cell (SR)
Lung cancer cell (A549)
Lung cancer cell (EKVX)
Lung cancer cell (HOP-62)
Lung cancer cell (HOP-92)
Lung cancer cell (NCI-H226)
Lung cancer cell (NCI-H23)
Lung cancer cell (NCI-H522)
Macrophage (THP1)
Mammary luminal epithelial cell (C5.2)
Mammary luminal epithelial cell (HB4a)
Melanoma cell (LOX IMVI)
Melanoma cell (M14)
Melanoma cell (MALME-3M)
Melanoma cell (MDA-MB-435)
Melanoma cell (SK-MEL-2)
Melanoma cell (SK-MEL-28)
Melanoma cell (SK-MEL-5)
Melanoma cell (UACC-257)
Melanoma cell (UACC-62)
Neuroblastoma cell (CHLA255)
Neuroblastoma cell (HTLA-230)
Neuroblastoma cell (IGR-N91)
Neuroblastoma cell (IGR-NB8)
Neuroblastoma cell (IMR32)
Neuroblastoma cell (LAN-1)
Neuroblastoma cell (SH-SY5Y)
Neuroblastoma cell (SK-N-SH)
Neuroblastoma cell (SKNBe2c)
Oral squamous cell carcinoma cell (BHY)
Osteosarcoma cell (SAOS-2)
Osteosarcoma cell (U2OS)
Ovarian cancer cell (IGROV1)
Ovarian cancer cell (NCI-ADR-RES)
Ovarian cancer cell (OVCAR-3)
Ovarian cancer cell (OVCAR-4)
Ovarian cancer cell (OVCAR-5)
Ovarian cancer cell (OVCAR-8)
Ovarian cancer cell (SK-OV-3)
Pancreatic ductal adenocarcinoma cell (Pa09C)
Prostate cancer cell (DU145)
Prostate cancer cell (DuCaP)
Prostate cancer cell (LNCaP)
Prostate cancer cell (PC-3)
Prostate cancer cell (PC3)
Prostate cancer cell (VCaP)
Retinal pigment epithelium cell (ARPE-19)
Serum
Squamous carcinoma cell (A431)
T cell (Jurkat)
T cell blasts
Thymus
Trophoblast cell (Sw71)
Urine
By sample status
100K population
20K population
Activated_exosomes
Androgen-deprived
Apoptotic_exosomes
Bioreactor culture
Cocultured with C. albicans
Control_exosomes
Ectosome
Exosomes
Irradiated (6 Gy)
Microvesicles
Normal
Normal donors
Stressed (hypoxia, TNF-慣-induced activation, high glucose and mannose concentrations)
Treated by PAI-1
Treated by TNF-alpha
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Protein name
UniProt accession
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
Matrin-3
P43243
Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells.
Mol Cell Proteomics. 2009 Oct;8(10):2201-11. doi: 10.1074/mcp.M900203-MCP200. Epub 2009 Jun 29.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.
Mol Cell Proteomics. 2010 Jun;9(6):1085-99. doi: 10.1074/mcp.M900381-MCP200. Epub 2010 Feb 1.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells.
Exp Cell Res. 2011 May 1;317(8):1192-202. doi: 10.1016/j.yexcr.2011.01.014. Epub 2011 Jan 26.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.
J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Characterization of human thymic exosomes.
PLoS One. 2013 Jul 2;8(7):e67554. doi: 10.1371/journal.pone.0067554. Print 2013.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18396. eCollection 2012.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.
PLoS One. 2013 Sep 19;8(9):e75054. doi: 10.1371/journal.pone.0075054. eCollection 2013.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
PLoS One. 2013 Dec 31;8(12):e82589. doi: 10.1371/journal.pone.0082589. eCollection 2013.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles.
Proteomics. 2014 Jun;14(12):1472-9. doi: 10.1002/pmic.201300485. Epub 2014 May 15.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes.
Oncotarget. 2015 Apr 12.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.
Sci Rep. 2016 Jan 7;6:18346. doi: 10.1038/srep18346.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.
Oncotarget. 2016 Apr 11. doi: 10.18632/oncotarget.8678.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.
Oncotarget. 2016 Apr 11. doi: 10.18632/oncotarget.8678.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling.
Analyst. 2016 May 27.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components.
PLoS One. 2016 Sep 20;11(9):e0163043. doi: 10.1371/journal.pone.0163043. eCollection 2016.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Candida albicans Modifies the Protein Composition and Size Distribution of THP1 macrophages-derived Extracellular Vesicles.
J Proteome Res. 2016 Oct 14.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Candida albicans Modifies the Protein Composition and Size Distribution of THP1 macrophages-derived Extracellular Vesicles.
J Proteome Res. 2016 Oct 14.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure.
J Extracell Vesicles. 2017 Apr 19;6(1):1302705. doi: 10.1080/20013078.2017.1302705. eCollection 2017.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure.
J Extracell Vesicles. 2017 Apr 19;6(1):1302705. doi: 10.1080/20013078.2017.1302705. eCollection 2017.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.
Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103.
ENOG410XSPB
143
/
0
/
143
Matrin-3
P43243
Motile hepatocellular carcinoma cells preferentially secret sugar metabolism regulatory proteins via exosomes.
Proteomics. 2017 Jun 7. doi: 10.1002/pmic.201700103.
ENOG410XSPB
143
/
0
/
143
[1]
[2]